Search results

Selected filters:

Europe
Market Developments

Article type

Topic

Sector

Jurisdictions

162 results found for your search

Sort options
19 November 2019

Shorter EPO opposition process requires new approaches from life sciences patentees

Strategies employed not only by rights owners but also by those opposing their grants will need to be recalibrated to reflect the new realities

14 November 2019

Skyhawk deal with Celgene confirms growing importance of platform technologies in life sciences IP value creation

Increased focus on gene and cell-related therapies as well as falling R&D returns, promise to heighten biopharma interest in tapping into the potential of SkySTAR and other platforms

12 November 2019

US government patent suit against Gilead could be a sign of things to come

After months of Truvada controversy, Department of Justice files multi-billion dollar case against Gilead, claiming the company has declined to take a licence to its HIV PrEP rights since in 2016

08 November 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019

02 November 2019

UK general election could result in a paradigm shift on pharma IP

The Labour Party – the main opposition to Boris Johnson’s Conservatives – recently set out a radical plan to change the patent regime for life sciences innovators

29 October 2019

Four key IP implications from the rise of orphan drugs

The growing importance of rare disease treatments has strategic, commercial and potential political ramifications for life sciences IP

25 October 2019

Intel faces multi-pronged injunction threat in China, antitrust suit reveals

Fortress-owned vehicle monetising NXP rights has brought multiple Chinese suits as part of its pressure campaign on the US chipmaker

24 October 2019

Exclusive: Inside the IP protection strategy of an innovative generic

Centrient’s head of IP lifts the lid on why the company has been putting more focus on IP enforcement in India and explains the attractions of trade secrets

24 October 2019

Latest statistics show foreign firms win in high numbers at Beijing IP Court

Numbers also show that damages are rising. But litigation statistics only tell part of the story on plaintiff success.

23 October 2019

IBM patent transaction puts Indian IT firm on par with rivals

Around 200 patents change hands as Big Blue selloff continues and a new HCL IP executive strikes first known deal

22 October 2019

Ericsson and Xiaomi strike global licence

The parties settle after nearly five years of litigation in the Delhi High Court, but are keeping the deal and its terms quiet

14 October 2019

Nokia seeks to reset the 5G patent narrative

A recent announcement is the first time that the Finnish company has drawn attention to the release of SEPs and comes after months of stories about Chinese dominance of the technology

09 October 2019

IBM has the world's most valuable patent portfolio, new analysis claims

Samsung, Canon, Microsoft and Bosch round-out the top five who, between them, are said to own assets worth well in excess of $35 billion

03 October 2019

Chip foundries bring high-stakes patent litigation to Singapore

TSMC hits back against Globalfoundries with countersuits in the US, Germany and Singapore. The headline grabbing dispute takes place as the Lion City attempts to lure more cases with legal reforms

27 September 2019

Huawei’s FRAND strategy: move cases to China

The company wants to shift disputes to its home jurisdiction and persuade courts there to set a low, China-specific rate